× Industry Reports Services Press Release Contact us About us

Europe Precision Medicine Market Forecast 2027 By End-use (Hospitals, Diagnostic Centers, Research & Academic Institutes), By Product Type (Diagnostics {Genetic Tests, Biomarker Based Tests}, Therapeutics), By Application (Oncology, CNS, Immunology, Respiratory), Research Report, Country Outlook (Germany, France, UK, Italy, Spain, Denmark, Sweden, Finland, Norway), COVID-19 Impact Statistics, Price Trends, Historic Data, Growth Prospects, Competitive Industry Share
Published Date: September 2021 | Publisher: Graphical Research Report ID: GR1953 | Delivery : PDF  Request Free Sample

Europe Precision Medicine Market size crossed USD 12.9 million in 2020 and is predicted to expand at a CAGR of over 11.2% from 2021 to 2027. Growing number of personalized medication drugs will boost the market growth.

Europe Precision Medicine Market

Get more details on this report - Request Free Sample PDF

Precision medicine is about treating the right patients with the right medicines. At its core, precision medicine embodies an effort to understand the underlying cause of disease in individual patients. In recent years, industry players have been particularly active in the precision medicine ecosystem, combining computer science breakthroughs with laboratory work and clinical discovery. Pharmaceutical companies are heavily investing in research and collaborations with healthcare providers and others to expand their precision medicine drug portfolios. They are focused on investigating functional, phenotypic, and genetic biomarkers to distinguish target populations that will guide clinical strategies.

Europe Market, By Product Type

The diagnostics segment in the Europe precision medicine market is poised to grow at 12.5% CAGR through 2027. The diagnostics section is further fragmented into biomarker-based tests and genetic tests among others. Diagnostic testing is a technique for the identification of patients for the targeted treatment based on person’s genetic composition. Various treatment based on accurate diagnosis leads to better treatment results as well as management.

Europe Market, By Application

Europe Precision Medicine Market, By Application

Get more details on this report - Request Free Sample PDF

The immunology segment held more than 8% Europe precision medicine market share in 2020, owing to surging incidence of immunology disorders throughout the Europe. Immunodeficiency disorders are either acquired or congenital and include disorders such as AIDS, leukemia, and immune-complex diseases among others. Therefore, surging prevalence of such health aliments will accelerate the demand for personalized medications for effective patient care.

Europe Market, By End-use

The research & academic institutes accounted for around USD 2.5 billion market revenue in 2020, with rising healthcare expenditure as well as infrastructure, the number of research labs and institutes in developed economies is rapidly expanding. Similarly, according to specific patients need the research institutes works continuously on innovating the medications that propels the segment progression.

Europe Market, By Country

Germany dominated the Europe precision medicine market and is likely to showcase 10.5% growth rate during the forecast period. Growing awareness about the importance of personalized medication for the treatment of numerous health aliments including cancer will foster the industry size. In addition, Germany is one of the economies that have a high prevalence of cancer, thus it surges the demand for precision medicine in the country.

Competitive Industry Landscape

Some of the prominent industry players include Qiagen, Medtronic, Quest Diagnostics, Novartis, Abbott Laboratories, Laboratory Corporation of America Holdings, F. Hoffmann-La Roche AG, bioMérieux SA, Eli Lilly & Company, AstraZeneca, Glaxosmithkline, Cancer Genetics, Cepheid, Thermo Fisher Scientific, Foundation Medicine, Bristol-Myers Squibb, Myriad Genetics and Pfizer.
 

Frequently Asked Question(FAQ) :

The market size for precision medicine in Europe had surpassed USD 12.9 billion during 2020, with a 11.2% CAGR predicted over 2021-2027 with increased investments in R&D and collaborations with healthcare providers.
Some of the major factors expanding precision medicine demand in Europe include the demand for diagnostic products like genetic tests and biomarker-based tests, high R&D spending, increased demand across diagnostic centers and significant adoption for cancer treatment.
Immunology applications held over 8% of Europe industry share in 2020 with increased prevalence of immunodeficiency disorders, which can either be acquired or congenital, such as leukemia, AIDS and immune-complex diseases.
The market size for precision medicine in Germany is expected to witness around 10.5% CAGR over 2021-2027 with increased spending on treatment of chronic diseases and high prevalence of cancer.
Major companies in Europe industry are AstraZeneca, Cepheid, Novartis, Quest Diagnostics, Medtronic, Abbott Laboratories, Glaxosmithkline, Eli Lilly & Company, Thermo Fisher Scientific, Bristol-Myers Squibb, and some others.

Premium Report

Have questions?
  • Inquire Before Buying
  • Why Choose us?

    • on-time delivery On-Time Delivery

      We commit to on-time delivery of reports to keep you ahead.

    • assured quality Assured Quility

      With a wide network of industry experts and trained in-house analysts, we assure best service quality.

    • Custom Research Service

      We offer research services to meet specific client requirements and provide them with actionable insights on target markets.

    • payment security Payment Security

      Our safe payment gateway gives you full control of your personal data, at all times.

    Connect with our sales team

     1-800-986-6917

     [email protected]